Addiction

Wearable Device Cleared for Use During Opioid Detoxification

Wearable Device Cleared for Use During Opioid Detoxification

By

Electrical pulses are sent through small needles that are inserted in the ear to combat the early stages of detoxification, leading to stabilization.

AAFP Joins Call on FDA to Reduce Nicotine Content in Cigarettes

AAFP Joins Call on FDA to Reduce Nicotine Content in Cigarettes

AAFP and other signatories also call on FDA to apply the proposal to other combustible tobacco products.

Financial Incentives May Up Rates of Smoker Abstinence

Financial Incentives May Up Rates of Smoker Abstinence

Financial incentives added to free cessation aids can improve the rate of sustained abstinence among smokers.

FDA Warns Websites Marketing Unapproved Opioids

FDA Warns Websites Marketing Unapproved Opioids

Nine online networks, operating 53 websites, have been warned that they must stop illegally marketing potentially dangerous versions of opioid medications.

Greater Use of Tobacco Products Among Youth With Asthma

Greater Use of Tobacco Products Among Youth With Asthma

Youth with asthma have considerably higher use of tobacco products than those without asthma.

2011 to 2017 Saw Drop in Youth Use of Any Tobacco Products

2011 to 2017 Saw Drop in Youth Use of Any Tobacco Products

From 2011 to 2017 there were decreases in current use of any tobacco products among high and middle school students.

Higher Risk for Substance Abuse Among Reservation-Based American Indian Youth

Higher Risk for Substance Abuse Among Reservation-Based American Indian Youth

By

Researchers emphasized the necessity of developing targeted interventions to address such health disparities among American Indian communities.

UK National Health Service Explores Justification for Rationing Elective Surgery in Smokers, Obesity

UK National Health Service Explores Justification for Rationing Elective Surgery in Smokers, Obesity

By

Recent measures in the United Kingdom have proposed restricting access to elective surgery for smokers and people with obesity.

CDC Report: Integrating Tobacco Cessation Interventions in Mental Health, Substance Abuse Treatment Facilities

CDC Report: Integrating Tobacco Cessation Interventions in Mental Health, Substance Abuse Treatment Facilities

By

Providing barrier-free access to proven cessation treatments is critical to reduce smoking-related disease and death in the United States.

FDA Issues Warning to Companies Selling Kratom-Containing Products

FDA Issues Warning to Companies Selling Kratom-Containing Products

By

The US Food and Drug Administration has issued warnings to 3 companies selling kratom-containing products with unsubstantiated claims regarding their effectiveness in conditions that include opioid withdrawal and addiction and chronic pain.

Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy

Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy

By

While many treatments for substance use disorder are not evidence based, several evidence-based approaches have shown effectiveness in court-mandated treatment settings.

Recommended Risk Thresholds for Alcohol Consumption Should Be Lower Worldwide

Recommended Risk Thresholds for Alcohol Consumption Should Be Lower Worldwide

By

Data support lowering limits for alcohol consumption compared with the limits in current guidelines.

Global Prevalence of Alcohol, Tobacco, and Illicit Drug Use: A 2017 Status Report

Global Prevalence of Alcohol, Tobacco, and Illicit Drug Use: A 2017 Status Report

By

Researchers proposed that future projects investigate the geographical and temporal trends in substance use and its disease burden.

HIV Viral Suppression Rates in Psychiatric Inpatients With Comorbid Substance Use Disorders

HIV Viral Suppression Rates in Psychiatric Inpatients With Comorbid Substance Use Disorders

By

A substantial proportion of these individuals diagnosed with HIV, psychiatric disorders, and substance use disorders are out of care and urgently require intervention.

Long-acting buprenorphine depot injections may be efficacious in treatment of opioid use disorder

Weekly or monthly buprenorphine depot injections were non-inferior to daily sublingual buprenorphine/naloxone in maintaining no evidence of illicit opioid use at 24 weeks in outpatients with opioid use disorder.

Unit-dose packaging of buprenorphine-naloxone associated with reduced pediatric unintentional exposures

Pediatric unintentional opioid exposures decreased by more than 75% following the introduction of child-resistant unit-dose packaging.

Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes

Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes

By

Patients who use medical marijuana may be more likely to use prescription drugs for both medical and nonmedical purposes.

First Nonopioid Drug Approved for Managing Opioid Withdrawal Symptoms

First Nonopioid Drug Approved for Managing Opioid Withdrawal Symptoms

By

Lucemyra, a selective alpha 2-adrenergic receptor agonist, works by reducing the release of norepinephrine and decreasing sympathetic tone.

Opioid-Related Payments Linked to Increase in Opioid Rx

Opioid-Related Payments Linked to Increase in Opioid Rx

Receipt of opioid-related payments from industry in 2014 was associated with increased opioid prescribing in 2015.

Efficacy of Prazosin in Treating Alcohol Use Disorder

Efficacy of Prazosin in Treating Alcohol Use Disorder

By

Participants in the prazosin group were more likely to experience dizziness on standing.

Lofexidine Effective for Opioid Withdrawal Symptoms

Lofexidine Effective for Opioid Withdrawal Symptoms

By

Investigators pooled data from 2 phase 3 placebo-controlled studies to evaluate the safety and efficacy of lofexidine for opioid withdrawal symptoms.

Sources of Misused Opioids in Older Adults

Sources of Misused Opioids in Older Adults

By

Recent physician-prescribed opioids represent the main source of provenance of the drug in individuals age ≥65 years who misuse them.

Contribution of Synthetic Opioids to Drug Overdose Deaths

Contribution of Synthetic Opioids to Drug Overdose Deaths

By

Opioids were the leading contributor to drug overdose deaths between 2015 and 2016.

Motivations of Stimulant Misuse in Adults in the United States

Motivations of Stimulant Misuse in Adults in the United States

By

Investigators examined the prevalence of prescription stimulant use, misuse, use disorder, and motivations for misuse in adults in the US from 2015 to 2016.

Substance Use Disorders Associated With Conversion From Schizotypal Disorder to Schizophrenia

Substance Use Disorders Associated With Conversion From Schizotypal Disorder to Schizophrenia

By

These data may be helpful in titrating care for those with schizotypal disorder and comorbid substance abuse disorders to mitigate the risk for conversion to schizophrenia.

Smoking Cessation Pharmacotherapies May Not Increase MACE

Smoking Cessation Pharmacotherapies May Not Increase MACE

By

There were no observable differences in the incidence of any cardiovascular events across the smoking cessation treatment groups.

Methadone Maintenance Therapy Associated With Greater Access to Physician Care in HCV-Positive Drug Users

Methadone Maintenance Therapy Associated With Greater Access to Physician Care in HCV-Positive Drug Users

By

The investigators suggest that enrollment in a methadone maintenance therapy program may be helpful in providing access to HCV care in people who inject drugs.

Knowledge Not Tied to Addictive Tanning Behavior in Millennials

Knowledge Not Tied to Addictive Tanning Behavior in Millennials

For millennials, sun protection knowledge is not associated with addictive tanning behavior.

Intranasal Esketamine Rapidly Improves Symptoms of Depression and Suicidality

Intranasal Esketamine Rapidly Improves Symptoms of Depression and Suicidality

By

Although there were no indications of esketamine dependence, misuse, diversion, or withdrawal symptoms in this trial, this is a possible concern, and the authors call for further evidence from clinical trials to evaluate the drug's potential for abuse.

April 28 Is Drug Take Back Day

April 28 Is Drug Take Back Day

By

April 28, 2018 is National Prescription Drug Take Back Day.

Sign Up for Free e-newsletters